How much funding has Intuitive Biosciences raised?

Intuitive Biosciences has disclosed $3M raised across 3 rounds.

Where is Intuitive Biosciences headquartered?

Intuitive Biosciences is headquartered in Middleton, US.

Intuitive Biosciences

Middleton, US · Founded 2012 · Wisconsin corporation

Find your way into Intuitive Biosciences

Each arrow is one introduction. Sign up to fill in the first one.

107 people can intro you to John

Ask David Goldschlag to introduce you to John Bart

You →David · together at Naval Research Laboratory →John

54 people can intro you to Kimberly

Ask Jamie Chen to introduce you to Kimberly Luke

You →Jamie · together at Integrated Genomics →Kimberly

Your email: who you already know at Intuitive Biosciences, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Intuitive Biosciences team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Intuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.

Biotech Healthtech Medical Devices

Founders & leadership

Shawn GusePresident and CEO

Kimberly Luke Vice President of Research and DevelopmentVice President of Research and Development at Intuitive Biosciences, Kimberly Luke leads product development and research initiatives focused on diagnostic assays for infectious disease detection. Her background includes expertise in immunoassay platform development, in vitro diagnostic development, and work on biomarker research including extracellular vesicle characterization.

John Bart Vice President of OperationsJohn Bart has over 20 years of experience in product development, manufacturing, and quality assurance across protein microarrays, medical diagnostics, and immunosensors. He is Vice President of Operations at Intuitive Biosciences.

Jason R. SmithNamed on SEC filing

Board

Harald NordalBoard director

Craig E SmithBoard director

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 3 rounds · 2014–2019

▶$1.2MraisedOct 2019 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Craig SmithDirector
Jason R SmithDirector
Johan MichelsenDirector
Shawn D GuseExecutive Officer, Director
Jay SekelskyDirector

Offering amount: $1.2M
Amount sold: $1.2M
First sale: Sep 2019
Incorporated: Corporation, Wisconsin
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.3MraisedJun 2015 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Harald NordalDirector
Craig E SmithDirector
Jason R SmithDirector
Shawn D GuseExecutive Officer, Director

Offering amount: $2.9M
Amount sold: $1.3M
First sale: May 2015
Incorporated: Corporation, Wisconsin, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$486.9KraisedAug 2014 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Craig SmithDirector
Jason R. SmithDirector
Harald NordalExecutive Officer, Director
Shawn D GuseExecutive Officer, Director

Offering amount: $500K
Amount sold: $486.9K
First sale: Aug 2014
Incorporated: Corporation, Wisconsin, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

Life BiosciencesLife Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.

Twist BioscienceTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.

Companies working in the same space as Intuitive Biosciences.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2023	$306.2K
National Institutes of Health (NIH)National Institutes of Health	Phase I	2022	$299.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Intuitive Biosciences do?: Intuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
How much funding has Intuitive Biosciences raised?: Intuitive Biosciences has disclosed $3M raised across 3 rounds.
Where is Intuitive Biosciences headquartered?: Intuitive Biosciences is headquartered in Middleton, US.